The protein expression levels of NHE1 as well as NBCn1 were elevated in breast carcinomas with HER2 overexpression or gene amplification both before (Figure 5E,F) and after (Figure 6E,F) adjustment for other clinicopathological characteristics. This evidence concerns the gene ERBB2 and breast carcinoma.